ME Therapeutics Holdings Inc. (CSE:METX)

Canada · Delayed Price · Currency is CAD

1.750

-2.350 (-57.32%)

At close: Sep 18, 2026

ME Therapeutics Holdings Financials Overview

Financials in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Operating Income	-1.55	-1.28	-1.37	-0.98	-0.15	-0.07
Net Income	-1.38	-1.19	-1.29	-6.52	-0.15	-0.07
Earnings Per Share	-0.05	-0.04	-0.05	-0.42	-0.02	-0.01
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Cash & Investments	0.54	1.4	1.5	0.65	0.08	0.07
Total Debt	0.03	0.07	-	0.04	0.19	0.06
Net Cash (Debt)	0.51	1.33	1.5	0.61	-0.12	0.01
Net Cash Growth	-68.62%	-11.06%	146.52%	-	-	34.62%
Net Cash Per Share	0.02	0.05	0.06	0.04	-0.01	0.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Operating Cash Flow	-1.21	-0.86	-0.66	-0.3	-0.14	0
Capital Expenditures	-0.08	-0.22	-	-	-	-
Free Cash Flow	-1.29	-1.08	-0.66	-0.3	-0.14	0
Free Cash Flow Growth	-	-	-	-	-	-

Valuation

Selected indicators aren't available for this stock.